Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by cannhealthon Oct 05, 2019 8:17pm
413 Views
Post# 30200452

A Reality Check For ALL CDN Cannabis Investors & EMH

A Reality Check For ALL CDN Cannabis Investors & EMH
What's happening now with the reduction in market cap of CDN LPs has nothing to do with the future viability and value multiples of said CDN LPs. It's a fabrication. A fabrication led largely by the U.S. Hedge Funds and even domestic market makers the likes of RBC Dominion Securities and others.

Step back for a moment, if you can, and look what's occurring worldwide with the cannabis industry itself.

Firstly.. in the largest consumer cannabis market in the world, the U.S., cannabis aside (possibly) of hemp, is federally illegal. And.. aside of medicinal pot, most countries in the world treat cannabis as a controlled substance without ANY form of legalization on a national level. Hence.. CDN LPs, since national legalization, have leaped far ahead of any other LP, in any other country, in the research into growing, processing, extraction, predictable dosing and isolation of compounds valuable for the treatment of chronic disease and disorders.

So... is it any wonder the U.S. Hedge Funds and even our own CDN market makers are shorting the MJ Market. They want your shares. Full Stop. They can't make money by OWNing the company or even financing it because it's illegal. The best they can do is run the market down by shorting, covering, going long and repeating. It's a nasty scenario to be share for honest investors. Paper losses for everyone may look awful at this point, but it does not mean EMH is not making all the correct moves. In fact, I can argue they're making all the right moves. This said, I won't waste my time arguing on this board with the likes of Market BS who's nothing more than a hedge fund or market maker, boiler room flunky.. and nor should anyone else here.

Right now EMH particularly is a huge Buy. Is there another LP right now with as much credibility based on their delivery of promises to shareholders? Is there another and better LP developing all facets of the MJ business for both the present, short and long-term future cannabis environment worldwide?

<< Previous
Bullboard Posts
Next >>